androstenedione has been researched along with Neoplasm Metastasis in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (44.83) | 18.7374 |
| 1990's | 12 (41.38) | 18.2507 |
| 2000's | 4 (13.79) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, Z; Liu, X; Song, S; Wang, T; Wu, S; Yu, J | 1 |
| Carlini, P; Cognetti, F; Colella, E; Di Cosimo, S; Fabi, A; Ferretti, G; Frassoldati, A; Papaldo, P; Romiti, A; Ruggeri, EM; Tomao, S; Tonachella, R | 1 |
| Baelde, HJ; Bovée, JV; Cleton-Jansen, AM; Hogendoorn, PC; Karperien, M; van Beerendonk, HM | 1 |
| Smith, IE; Stuart-Harris, RC | 1 |
| Dowsett, M; Jacobs, S; Lonning, PE; MacNeill, FA; Powles, TJ | 1 |
| Murray, R; Pitt, P | 1 |
| Attili, A; Bajetta, E; Bartoli, C; Buzzoni, R; Ferrari, L; Lepera, P; Martinetti, A; Noberasco, C; Sacchini, V; Zilembo, N | 1 |
| Alberola Candel, V; Calabresi, F; Delozier, T; Feuilhade, F; Freue, M; Goss, P; Mauriac, L; Michel, RT; Pérez Carrión, R; Santos, R | 1 |
| Höffken, K; Jonat, W; Possinger, K | 1 |
| Bajetta, E; Buzzoni, R; Celio, L; Cerrotta, AM; Ferrari, L; Galante, E; Martinetti, A; Noberasco, C; Orefice, S; Zilembo, N | 1 |
| Hakky, SI; Hudson, PB; Lombardo, ME | 1 |
| Rose, C | 1 |
| Bonnefoi, H; Castiglione, M; Cavalli, F; Fey, MF; Goldhirsch, A; Hsu-Schmitz, SF; Löhnert, T; Morant, R; Thürlimann, B | 1 |
| Ekse, D; Giurescu, M; Helle, SI; Holly, JM; Jonat, W; Lønning, PE | 1 |
| Alonso, MC; Español, I; Muñíz-Díaz, E; Pujol-Moix, N | 1 |
| Coombes, RC; Ford, HT; Gazet, JC; Gray, R; Lowndes, S; Makinde, V; McConkey, C; Quilliam, J; Sutcliffe, R | 1 |
| Harvey, H; Lipton, A; Samojlik, E; Santen, RJ; Veldhuis, J; Wells, SA | 1 |
| Ifuku, M; Maeyama, M; Nakahara, K | 1 |
| Siiteri, PK; Walsh, PC | 1 |
| Deshpande, N | 1 |
| Bulbrook, RD; Hayward, JL; Wang, DY | 1 |
| Harvey, H; Kendall, J; Lipton, A; Ruby, EB; Samojlik, E; Santen, RJ; Wells, SA | 1 |
| Dilley, WG; Haagensen, DE; Harvey, H; Lipton, A; Ruby, EJ; Santen, RJ; Wells, SA | 1 |
| Bellora, MG; Bergamino, T; Ciancio, A; Ferrero, A; Sismondi, P; Zola, P | 1 |
| Al-Sarraf, M; Decker, DA; Kresge, C; Subramanian, MG; Tapazoglou, E | 1 |
| Doorenbos, H; Sleijfer, DT; Sluiter, WJ; van Veelen, H; Willemse, PH | 1 |
| Bezwoda, WR; Dansey, R; Esser, JD; Mansoor, N | 1 |
| Brodie, AM; Coombes, RC; Cunningham, D; Dowsett, M; Ford, HT; Gazet, JC; Hutchison, G; Powles, TJ | 1 |
| Beardwell, CG; Bu'lock, D; Hindley, AC; St John, J; Wilkinson, PM | 1 |
3 review(s) available for androstenedione and Neoplasm Metastasis
| Article | Year |
|---|---|
Aminoglutethimide in the treatment of advanced breast cancer.
Topics: Adrenalectomy; Aged; Aminoglutethimide; Androstenedione; Breast Neoplasms; Clinical Trials as Topic; Dehydroepiandrosterone; Drug Therapy, Combination; Estradiol; Estrone; Female; Glucocorticoids; Humans; Hydrocortisone; Hypophysectomy; Menopause; Middle Aged; Neoplasm Metastasis; Tamoxifen | 1984 |
Proper sequence of endocrine therapies in advanced breast cancer.
Topics: Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Enzyme Inhibitors; Female; Humans; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Postmenopause; Premenopause | 1996 |
Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer.
Topics: Adrenocorticotropic Hormone; Aldosterone; Aminoglutethimide; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Dexamethasone; Drug Therapy, Combination; Estradiol; Estrone; Female; Humans; Hydrocortisone; Menopause; Neoplasm Metastasis; Neoplasm Recurrence, Local; Thyrotropin; Thyroxine | 1977 |
11 trial(s) available for androstenedione and Neoplasm Metastasis
| Article | Year |
|---|---|
[Clinical trial of lentaron for postmenopausal patients with advanced breast cancer].
Topics: Androstenedione; Antineoplastic Agents; Breast Neoplasms; Disease Progression; Female; Humans; Neoplasm Metastasis; Neoplasm Staging; Postmenopause; Treatment Outcome | 2002 |
Is there a benefit by the sequence anastrozole-formestane for postmenopausal metastatic breast cancer women?
Topics: Adult; Aged; Anastrozole; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Drug Administration Schedule; Enzyme Inhibitors; Female; Humans; Middle Aged; Neoplasm Metastasis; Nitriles; Postmenopause; Receptors, Estrogen; Tamoxifen; Triazoles | 2003 |
Aminoglutethimide in the treatment of advanced breast cancer.
Topics: Adrenalectomy; Aged; Aminoglutethimide; Androstenedione; Breast Neoplasms; Clinical Trials as Topic; Dehydroepiandrosterone; Drug Therapy, Combination; Estradiol; Estrone; Female; Glucocorticoids; Humans; Hydrocortisone; Hypophysectomy; Menopause; Middle Aged; Neoplasm Metastasis; Tamoxifen | 1984 |
The effects of oral 4-hydroxyandrostenedione on peripheral aromatisation in post-menopausal breast cancer patients.
Topics: Administration, Oral; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Dose-Response Relationship, Drug; Estradiol; Female; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Postmenopause | 1995 |
Formestane: effective therapy in postmenopausal women with advanced breast cancer.
Topics: 17-Hydroxycorticosteroids; Aged; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Disease-Free Survival; Estradiol; Female; Humans; Middle Aged; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Postmenopause; Receptors, Estrogen | 1994 |
Comparison of the selective aromatase inhibitor formestane with tamoxifen as first-line hormonal therapy in postmenopausal women with advanced breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Middle Aged; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Postmenopause; Receptors, Estrogen; Survival Analysis; Tamoxifen | 1994 |
Formestane in the treatment of advanced postmenopausal breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Estradiol; Female; Humans; Injections, Intramuscular; Middle Aged; Neoplasm Metastasis; Postmenopause; Remission Induction | 1994 |
Effect of two-4-hydroxyandrostenedione doses on serum insulin-like growth factor I levels in advanced breast cancer.
Topics: Aged; Androstenedione; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Insulin-Like Growth Factor I; Middle Aged; Neoplasm Metastasis; Postmenopause; Time Factors | 1994 |
Formestane versus megestrol acetate in postmenopausal breast cancer patients after failure of tamoxifen: a phase III prospective randomised cross over trial of second-line hormonal treatment (SAKK 20/90). Swiss Group for Clinical Cancer Research (SAKK)
Topics: Adult; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cross-Over Studies; Female; Humans; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Postmenopause; Prospective Studies; Receptors, Estrogen; Regression Analysis; Remission Induction; Tamoxifen; Time Factors; Treatment Failure | 1997 |
Estrogen-receptor-directed neoadjuvant therapy for breast cancer: results of a randomised trial using formestane and methotrexate, mitozantrone and mitomycin C (MMM) chemotherapy.
Topics: Adult; Aged; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Goserelin; Humans; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Neoadjuvant Therapy; Neoplasm Metastasis; Postmenopause; Premenopause; Prognosis; Receptors, Estrogen; Survival Analysis | 2001 |
Endocrine effects of medroxyprogesterone acetate: relation between plasma levels and suppression of adrenal steroids in patients with breast cancer.
Topics: Adrenal Glands; Aged; Androstenedione; Breast Neoplasms; Clinical Trials as Topic; Dehydroepiandrosterone; Estrone; Female; Hormones; Humans; Hydrocortisone; Medroxyprogesterone; Middle Aged; Neoplasm Metastasis; Netherlands; Random Allocation | 1985 |
16 other study(ies) available for androstenedione and Neoplasm Metastasis
| Article | Year |
|---|---|
Estrogen signaling is active in cartilaginous tumors: implications for antiestrogen therapy as treatment option of metastasized or irresectable chondrosarcoma.
Topics: Adult; Aged; Androstadienes; Androstenedione; Aromatase; Aromatase Inhibitors; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Chondrosarcoma; Dose-Response Relationship, Drug; Estrogen Antagonists; Estrogens; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Neoplasm Metastasis; Receptors, Estrogen; RNA, Messenger; Signal Transduction | 2005 |
Treatment of advanced breast cancer with formestane.
Topics: Adult; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Middle Aged; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Remission Induction; Survival Analysis | 1994 |
Testicular androgens in prostate cancer patients treated with a luteinizing hormone releasing hormone agonist.
Topics: 17-Hydroxysteroid Dehydrogenases; Aged; Aged, 80 and over; Androgens; Androstenedione; Humans; Leuprolide; Male; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms; Testis; Testosterone | 1994 |
Influence of treatment with onapristone on the IGF-system in breast cancer patients.
Topics: Adult; Aged; Androstenedione; Antineoplastic Agents; Blotting, Western; Breast Neoplasms; Female; Gonanes; Hormone Antagonists; Humans; Hydrocortisone; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor Binding Protein 4; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Middle Aged; Neoplasm Metastasis; Postmenopause | 1998 |
Severe immune thrombocytopenia during formestane treatment.
Topics: Androstenedione; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Middle Aged; Neoplasm Metastasis; Postmenopause; Thrombocytopenia | 1998 |
Mechanism of action of aminoglutethimide in breast cancer.
Topics: Adult; Aged; Aminoglutethimide; Androstenedione; Breast Neoplasms; Estradiol; Estrogen Antagonists; Estrone; Female; Humans; Menopause; Middle Aged; Neoplasm Metastasis; Testosterone | 1979 |
Steroidogenesis in cerebral metastatic chorionepithelioma tissue in vitro.
Topics: 17-alpha-Hydroxypregnenolone; Androstenedione; Brain Neoplasms; Choriocarcinoma; Dehydroepiandrosterone; Estradiol; Estriol; Estrone; Female; Humans; In Vitro Techniques; Neoplasm Metastasis; Pregnancy; Progesterone; Steroids; Testosterone | 1975 |
Suppression of plasma androgens by spironolactone in castrated men with carcinoma of the prostate.
Topics: Aged; Androgens; Androstenedione; Castration; Dehydroepiandrosterone; Depression, Chemical; Humans; Male; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms; Spironolactone; Testosterone | 1975 |
Hormonal imbalance in breast cancer.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Androgens; Androstenedione; Breast Neoplasms; Cholesterol; Dehydroepiandrosterone; Female; Humans; Hydroxysteroid Dehydrogenases; Lyases; Neoplasm Metastasis; Pregnenolone; Progesterone; Steroid Isomerases | 1975 |
Plasma androstenedione levels in women with breast cancer.
Topics: 17-Ketosteroids; Aged; Androstenedione; Androsterone; Breast Neoplasms; Dehydroepiandrosterone; Female; Humans; Mastectomy; Menopause; Middle Aged; Neoplasm Metastasis | 1977 |
Medical adrenalectomy with aminoglutethimide: clinical studies in postmenopausal patients with metastatic breast carcinoma.
Topics: Adrenal Cortex; Adrenalectomy; Aldosterone; Aminoglutethimide; Androstenedione; Bone Neoplasms; Breast Neoplasms; Drug Evaluation; Estrogens; Female; Follow-Up Studies; Humans; Hypophysectomy; Lung Neoplasms; Menopause; Middle Aged; Neoplasm Metastasis; Prolactin; Radiography; Remission, Spontaneous; Thyrotropin; Thyroxine; Time Factors | 1978 |
[The use of aminoglutethimide in the treatment of metastatic breast cancer].
Topics: Adrenal Glands; Age Factors; Aminoglutethimide; Androstenedione; Breast Neoplasms; Female; Humans; Menopause; Neoplasm Metastasis | 1991 |
High-dose ketoconazole therapy in patients with metastatic prostate cancer.
Topics: Adenocarcinoma; Aged; Androstenedione; Combined Modality Therapy; Dehydroepiandrosterone; Dexamethasone; Dose-Response Relationship, Drug; Follicle Stimulating Hormone; Humans; Ketoconazole; Luteinizing Hormone; Male; Middle Aged; Neoplasm Metastasis; Orchiectomy; Prostatic Neoplasms; Testosterone | 1986 |
Aromatisation of androstenedione by human breast cancer tissue: correlation with hormone receptor activity and possible biologic significance.
Topics: Androstenedione; Aromatase; Breast Neoplasms; Estrone; Female; Humans; In Vitro Techniques; Menopause; NADP; Neoplasm Metastasis; Receptors, Estrogen; Receptors, Progesterone | 1987 |
Oral 4-hydroxyandrostenedione, a new endocrine treatment for disseminated breast cancer.
Topics: Administration, Oral; Adult; Aged; Androstenedione; Breast Neoplasms; Estradiol; Female; Humans; Menopause; Middle Aged; Neoplasm Metastasis; Ovariectomy | 1987 |
Hormonal changes in postmenopausal women with breast cancer treated with trilostane and dexamethasone.
Topics: Adrenal Cortex Hormones; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Dexamethasone; Dihydrotestosterone; Estrone; Female; Gonadal Steroid Hormones; Humans; Menopause; Neoplasm Metastasis | 1985 |